![]() The results showed a 36.3% improvement in EASI (Eczema Area and Severity Index) score from baseline for the patients who were treated with RPT193. RAPT stock spiked yesterday after it released positive trial results for its Phase 1b clinical trial of RPT193. It also has several other targets under development but these are in the discovery stage. The company has discovered and advanced two unique drug candidates, FLX475 and RPT193 for cancer and inflammation. Rapt Therapeutics is a clinical-stage biopharmaceutical company working on advancing the treatment for cancer and inflammation. ![]() What’s the forecast for the stock in 2021 and is it a good stock to buy in June 2021? ![]() Rapt Therapeutics (RAPT) stock rose over 115% yesterday and is trading higher in US premarket price action today also. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |